Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study.
<h4>Objectives</h4>Low 25(OH)D has been associated with dyslipidemia, insulin resistance and inflammation in both general and HIV-infected (mostly treated) populations. We investigated these associations in antiretroviral-naïve HIV-infected persons.<h4>Design</h4>We measured...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24058636/?tool=EBI |
id |
doaj-3fcffd0125a64aff88157194fca97bfd |
---|---|
record_format |
Article |
spelling |
doaj-3fcffd0125a64aff88157194fca97bfd2021-03-03T22:52:38ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0189e7486810.1371/journal.pone.0074868Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study.Camille LegeaiCorinne VigourouxJean-Claude SouberbielleOlivier BouchaudFaroudy BoufassaJean-Philippe BastardRobert CarlierJacqueline CapeauCécile GoujardLaurence MeyerJean-Paul ViardANRS-COPANA Cohort Study Group<h4>Objectives</h4>Low 25(OH)D has been associated with dyslipidemia, insulin resistance and inflammation in both general and HIV-infected (mostly treated) populations. We investigated these associations in antiretroviral-naïve HIV-infected persons.<h4>Design</h4>We measured plasma 25(OH)D, metabolic, immunologic and inflammatory markers in 355 persons (204 Whites, 151 Blacks) at enrollment in the ANRS COPANA cohort.<h4>Methods</h4>25(OH)D levels were categorized <10 ng/mL (severe deficiency) and <20 ng/mL (deficiency). Statistical analyses were adjusted for sampling season, ethnicity and the interaction between season and ethnicity.<h4>Results</h4>25(OH)D insufficiency (<30 ng/mL), deficiency (<20 ng/mL) and severe deficiency (<10 ng/mL) were highly prevalent (93%, 67% and 24% of patients, respectively). Blacks had significantly lower 25(OH)D than Whites (median: 13 vs. 17 ng/mL, P<0.001), with markedly less pronounced seasonal variation. Smoking and drinking alcohol were associated with having a 25 OHD level<10 ng/mL. In patients with 25(OH)D<10 ng/mL, the proportion of persons with a CD4 count<100/mm(3) was higher than in patients with 25(OH)D≥10 ng/mL (18.8% vs. 10.7%, P = 0.04). Persons with 25 OHD<10 ng/mL had higher levels of hsCRP (1.60 mg/L [IQR: 0.59-5.76] vs. 1.27 mg/L [0.58-3,39], P = 0.03) and resistin (16.81 ng/L [IQR: 13.82-25.74] vs. 11.56 ng/L [IQR: 8.87-20.46], P = 0.02), and, among Blacks only, sTNFR2 (2.92 ng/mL [2.31-4.13] vs. 2.67 ng/mL, [1.90-3.23], P = 0.04). The strength and significance of the association between CD4<100/mm(3) and 25 OHD<10 ng/mL were reduced after adjustment on sTNFR1, sTNFR2, and hsCRP levels. In multivariate analysis, a CD4 count <100/mm(3), resistin concentration and smoking were independently associated with 25(OH)D<10 ng/mL.<h4>Conclusions</h4>Severe vitamin D deficiency was associated with low CD4 counts and increased markers of inflammation in ARV-naïve HIV-infected persons.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24058636/?tool=EBI |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Camille Legeai Corinne Vigouroux Jean-Claude Souberbielle Olivier Bouchaud Faroudy Boufassa Jean-Philippe Bastard Robert Carlier Jacqueline Capeau Cécile Goujard Laurence Meyer Jean-Paul Viard ANRS-COPANA Cohort Study Group |
spellingShingle |
Camille Legeai Corinne Vigouroux Jean-Claude Souberbielle Olivier Bouchaud Faroudy Boufassa Jean-Philippe Bastard Robert Carlier Jacqueline Capeau Cécile Goujard Laurence Meyer Jean-Paul Viard ANRS-COPANA Cohort Study Group Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study. PLoS ONE |
author_facet |
Camille Legeai Corinne Vigouroux Jean-Claude Souberbielle Olivier Bouchaud Faroudy Boufassa Jean-Philippe Bastard Robert Carlier Jacqueline Capeau Cécile Goujard Laurence Meyer Jean-Paul Viard ANRS-COPANA Cohort Study Group |
author_sort |
Camille Legeai |
title |
Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study. |
title_short |
Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study. |
title_full |
Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study. |
title_fullStr |
Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study. |
title_full_unstemmed |
Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study. |
title_sort |
associations between 25-hydroxyvitamin d and immunologic, metabolic, inflammatory markers in treatment-naive hiv-infected persons: the anrs co9 «copana» cohort study. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2013-01-01 |
description |
<h4>Objectives</h4>Low 25(OH)D has been associated with dyslipidemia, insulin resistance and inflammation in both general and HIV-infected (mostly treated) populations. We investigated these associations in antiretroviral-naïve HIV-infected persons.<h4>Design</h4>We measured plasma 25(OH)D, metabolic, immunologic and inflammatory markers in 355 persons (204 Whites, 151 Blacks) at enrollment in the ANRS COPANA cohort.<h4>Methods</h4>25(OH)D levels were categorized <10 ng/mL (severe deficiency) and <20 ng/mL (deficiency). Statistical analyses were adjusted for sampling season, ethnicity and the interaction between season and ethnicity.<h4>Results</h4>25(OH)D insufficiency (<30 ng/mL), deficiency (<20 ng/mL) and severe deficiency (<10 ng/mL) were highly prevalent (93%, 67% and 24% of patients, respectively). Blacks had significantly lower 25(OH)D than Whites (median: 13 vs. 17 ng/mL, P<0.001), with markedly less pronounced seasonal variation. Smoking and drinking alcohol were associated with having a 25 OHD level<10 ng/mL. In patients with 25(OH)D<10 ng/mL, the proportion of persons with a CD4 count<100/mm(3) was higher than in patients with 25(OH)D≥10 ng/mL (18.8% vs. 10.7%, P = 0.04). Persons with 25 OHD<10 ng/mL had higher levels of hsCRP (1.60 mg/L [IQR: 0.59-5.76] vs. 1.27 mg/L [0.58-3,39], P = 0.03) and resistin (16.81 ng/L [IQR: 13.82-25.74] vs. 11.56 ng/L [IQR: 8.87-20.46], P = 0.02), and, among Blacks only, sTNFR2 (2.92 ng/mL [2.31-4.13] vs. 2.67 ng/mL, [1.90-3.23], P = 0.04). The strength and significance of the association between CD4<100/mm(3) and 25 OHD<10 ng/mL were reduced after adjustment on sTNFR1, sTNFR2, and hsCRP levels. In multivariate analysis, a CD4 count <100/mm(3), resistin concentration and smoking were independently associated with 25(OH)D<10 ng/mL.<h4>Conclusions</h4>Severe vitamin D deficiency was associated with low CD4 counts and increased markers of inflammation in ARV-naïve HIV-infected persons. |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24058636/?tool=EBI |
work_keys_str_mv |
AT camillelegeai associationsbetween25hydroxyvitamindandimmunologicmetabolicinflammatorymarkersintreatmentnaivehivinfectedpersonstheanrsco9copanacohortstudy AT corinnevigouroux associationsbetween25hydroxyvitamindandimmunologicmetabolicinflammatorymarkersintreatmentnaivehivinfectedpersonstheanrsco9copanacohortstudy AT jeanclaudesouberbielle associationsbetween25hydroxyvitamindandimmunologicmetabolicinflammatorymarkersintreatmentnaivehivinfectedpersonstheanrsco9copanacohortstudy AT olivierbouchaud associationsbetween25hydroxyvitamindandimmunologicmetabolicinflammatorymarkersintreatmentnaivehivinfectedpersonstheanrsco9copanacohortstudy AT faroudyboufassa associationsbetween25hydroxyvitamindandimmunologicmetabolicinflammatorymarkersintreatmentnaivehivinfectedpersonstheanrsco9copanacohortstudy AT jeanphilippebastard associationsbetween25hydroxyvitamindandimmunologicmetabolicinflammatorymarkersintreatmentnaivehivinfectedpersonstheanrsco9copanacohortstudy AT robertcarlier associationsbetween25hydroxyvitamindandimmunologicmetabolicinflammatorymarkersintreatmentnaivehivinfectedpersonstheanrsco9copanacohortstudy AT jacquelinecapeau associationsbetween25hydroxyvitamindandimmunologicmetabolicinflammatorymarkersintreatmentnaivehivinfectedpersonstheanrsco9copanacohortstudy AT cecilegoujard associationsbetween25hydroxyvitamindandimmunologicmetabolicinflammatorymarkersintreatmentnaivehivinfectedpersonstheanrsco9copanacohortstudy AT laurencemeyer associationsbetween25hydroxyvitamindandimmunologicmetabolicinflammatorymarkersintreatmentnaivehivinfectedpersonstheanrsco9copanacohortstudy AT jeanpaulviard associationsbetween25hydroxyvitamindandimmunologicmetabolicinflammatorymarkersintreatmentnaivehivinfectedpersonstheanrsco9copanacohortstudy AT anrscopanacohortstudygroup associationsbetween25hydroxyvitamindandimmunologicmetabolicinflammatorymarkersintreatmentnaivehivinfectedpersonstheanrsco9copanacohortstudy |
_version_ |
1714812111523151872 |